Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Somatic Gene Mutations on Prognosis Prediction in De Novo AML: Unraveling Insights from a Systematic Review and Meta-Analysis.

Cancers·2025
Same author

Assessment of psychosocial parameters in adolescents seeking orthodontic treatment.

BMC oral health·2024
Same author

Analysis of 14,392 whole genomes reveals 3.5% of Qataris carry medically actionable variants.

European journal of human genetics : EJHG·2024
Same author

Self-reported preferences and barriers to continued professional development in primary care physicians: a cross-sectional web-based survey in Qatar.

BMC primary care·2023
Same author

Rapid Maxillary Expansion Treatment in Patients with Cleft Lip and Palate: A Survey on Clinical Experience in the European Cleft Centers.

Journal of clinical medicine·2023
Same author

Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease.

Nature communications·2023

Related Experiment Video

Updated: Jun 12, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.3K

BRCA1-specific machine learning model predicts variant pathogenicity with high accuracy.

Mohannad Khandakji1,2, Hind Hassan Ahmed Habish3, Nawal Bakheet Salem Abdulla3

  • 1Division of Genomics and Translational Biomedicine, College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.

Physiological Genomics
|June 19, 2023
PubMed
Summary

A new machine learning model accurately predicts the pathogenicity of BRCA1 variants, aiding in breast cancer risk assessment. This tool identified potentially harmful BRCA2 variants in Qatari patients for further study.

Keywords:
BRCA2VUSbreast cancerin silico predictionsovarian cancer

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.7K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.5K

Related Experiment Videos

Last Updated: Jun 12, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.3K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.7K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.5K

Area of Science:

  • Genomics
  • Computational Biology
  • Oncology

Background:

  • Clinical annotation of novel BRCA1 variants lags behind identification, necessitating advanced computational tools for accurate risk assessment.
  • Breast cancer risk is significantly influenced by germline mutations in BRCA1 and BRCA2 genes.
  • Variants of Uncertain Significance (VUS) pose challenges in clinical genetic testing and patient management.

Purpose of the Study:

  • To develop a specialized machine learning model for predicting the pathogenicity of all BRCA1 variants.
  • To apply the developed BRCA1 model and a prior BRCA2 model to assess VUS in Qatari breast cancer patients.
  • To enhance the clinical interpretation of BRCA variants and improve breast cancer risk stratification.

Main Methods:

  • An XGBoost machine learning model was developed using variant features (position, frequency, consequence) and in silico prediction scores.
  • The model was trained and validated using BRCA1 variants classified by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) consortium.
  • Performance was further assessed on an independent set of missense VUS with experimentally determined functional scores.

Main Results:

  • The BRCA1 model achieved high accuracy (99.9%) in predicting pathogenicity for ENIGMA-classified variants.
  • The model demonstrated strong performance (93.4% accuracy) in predicting functional consequences for an independent set of missense VUS.
  • The models identified 2,115 potentially pathogenic BRCA1 variants from the BRCA Exchange database and four potentially pathogenic BRCA2 variants in Qatari patients.

Conclusions:

  • The developed BRCA1 machine learning model is highly effective for predicting variant pathogenicity, addressing a critical gap in clinical annotation.
  • Application of BRCA-specific models to Qatari breast cancer patients revealed no pathogenic BRCA1 variants but highlighted potentially pathogenic BRCA2 variants for validation.
  • These computational tools offer significant potential for improving genetic risk assessment and guiding clinical management of breast cancer patients.